Breaking News Instant updates and real-time market news.

HSDT

Helius Medical

$2.77

-0.15 (-5.14%)

07:09
06/18/19
06/18
07:09
06/18/19
07:09

Helius Medical to initiate study on physical therapy without use of PoNS device

Helius Medical Technologies is providing an update on its strategy to resubmit an application for De Novo clearance of its Portable Neuromodulation Stimulator device with the U.S. Food and Drug Administration. The company said, "Since the Company received the letter from the FDA in April denying its submission for De Novo clearance of the PoNS device, it has been developing a strategy to resubmit an application to the FDA. As part of that strategy, members of the Company's management participated in an informational discussion with the FDA on June 3rd regarding the issues the FDA raised in its April response letter. The FDA indicated that it denied the Company's request for clearance primarily because it was unable to ascertain the relative independent contributions of physical therapy and the PoNS device to the observed improvements in the balance of the Company's trial participants. The Company recognizes the importance of generating new clinical data demonstrating the independent contribution of physical therapy alone in its treatment protocol in order to demonstrate the overall impact of the PoNS Treatment on participants. The Company has concluded that, while it will not finalize its resubmission protocol until after it engages with the FDA in its pre-submission meeting, such a protocol will, at a minimum, need to include analyzing the effect of physical therapy alone, without use of the PoNS device. Accordingly, the Company proactively has decided to initiate a study to generate the physical therapy alone data. It has completed its new study protocol using the same design as its TBI 001 study including a 5-week treatment period and the same inclusion/exclusion requirements. In addition, the Company has identified sites at which to conduct this study and expects to be prepared to enroll participants by the end of July 2019. The Company is also in the process of drafting its pre-submission letter to the FDA requesting a pre-submission meeting. Following the pre-submission meeting, the Company expects to finalize its resubmission strategy and looks forward to reporting on that when completed."

HSDT Helius Medical
$2.77

-0.15 (-5.14%)

04/16/19
BTIG
04/16/19
DOWNGRADE
BTIG
Neutral
Helius Medical downgraded to Neutral from Buy at BTIG
BTIG analyst Sean Lavin downgraded Helius Medical to Neutral following last week's FDA announcement denying the company the request for de novo classification and 510(k) clearance for its Portable Neuromodulation Stimulator, or PoNS device. The analyst notes that there was some risk around the decision, but sees the decision as surprising since he believes that contrary to the FDA thinking, the company's submission "did separate" the impacts of the device and physical therapy toward symptom improvements. Lavin contends that Helius Medical may now have to conduct a new prospective trial which would require a "good deal of time and capital", adding that "significant dilution may be necessary."
04/16/19
BTIG
04/16/19
DOWNGRADE
BTIG
Neutral
Helius Medical downgraded to Neutral from Buy at BTIG
04/11/19
04/11/19
DOWNGRADE

Perform
Helius Medical downgraded to Perform on FDA PoNS update at Oppenheimer
As previously reported, Oppenheimer analyst Steven Lichtman downgraded Helius Medical to Perform from Outperform following the update on the FDA submission for the company's PoNS, with the agency declining approval and more data needed for resubmission. The next key milestones include the update on U.S. pathway following another expected FDA meeting and potential approvals in Europe/Australia, he contends.
04/11/19
OPCO
04/11/19
DOWNGRADE
OPCO
Perform
Helius Medical downgraded to Perform from Outperform at Oppenheimer

TODAY'S FREE FLY STORIES

LVMUY

LVMH

$0.00

(0.00%)

13:52
07/15/19
07/15
13:52
07/15/19
13:52
Hot Stocks
LVMH announces partnership with Stella McCartney »

Stella McCartney and LVMH…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

SCHW

Charles Schwab

$40.49

0.47 (1.17%)

13:51
07/15/19
07/15
13:51
07/15/19
13:51
Recommendations
Charles Schwab analyst commentary  »

Wells says Schwab deal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

AMC

AMC Entertainment

$9.45

(0.00%)

13:45
07/15/19
07/15
13:45
07/15/19
13:45
Options
AMC Entertainment call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

SPY

SPDR S&P 500 ETF Trust

$300.31

-0.37 (-0.12%)

, SPX

S&P 500

$0.00

(0.00%)

13:43
07/15/19
07/15
13:43
07/15/19
13:43
Periodicals
Trump ponders firing Commerce Secretary Wilbur Ross, NBC News says »

According to an earlier…

SPY

SPDR S&P 500 ETF Trust

$300.31

-0.37 (-0.12%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$36.65

-0.03 (-0.08%)

13:35
07/15/19
07/15
13:35
07/15/19
13:35
Options
Medicines Company put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTGN

Neon Therapeutics

$4.61

0.3 (6.96%)

13:30
07/15/19
07/15
13:30
07/15/19
13:30
Recommendations
Neon Therapeutics analyst commentary  »

Neon Therapeutics'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

SYMC

Symantec

$21.73

-3.83 (-14.98%)

, AVGO

Broadcom

$289.18

3.79 (1.33%)

13:27
07/15/19
07/15
13:27
07/15/19
13:27
Periodicals
Broadcom was willing to pay up $28.25 per share for Symantec, Reuters reports »

Symantec (SYMC) walked…

SYMC

Symantec

$21.73

-3.83 (-14.98%)

AVGO

Broadcom

$289.18

3.79 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARA

Cara Therapeutics

$25.55

1.25 (5.14%)

13:25
07/15/19
07/15
13:25
07/15/19
13:25
Options
Cara Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
07/15/19
07/15
13:25
07/15/19
13:25
Conference/Events
Stephens consumer/poultry & egg analysts hold analyst/industry conference call »

Analysts provide an…

A

Agilent

$69.90

-1.75 (-2.44%)

13:25
07/15/19
07/15
13:25
07/15/19
13:25
Conference/Events
The Brookings Institution to hold a conference »

8th annual Municipal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jul

GOOG

Alphabet

$1,146.02

1.47 (0.13%)

, GOOGL

Alphabet Class A

$1,146.04

0.74 (0.06%)

13:24
07/15/19
07/15
13:24
07/15/19
13:24
Periodicals
Trump administration 'taking aim' at Google, FBN's Gasparino says »

Charles Gasparino of Fox…

GOOG

Alphabet

$1,146.02

1.47 (0.13%)

GOOGL

Alphabet Class A

$1,146.04

0.74 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

  • 08

    Aug

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
07/15/19
07/15
13:17
07/15/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
07/15/19
07/15
13:16
07/15/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife Nutrition

$41.12

-0.47 (-1.13%)

13:15
07/15/19
07/15
13:15
07/15/19
13:15
Options
Herbalife put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

OSAGY

Osram

$0.00

(0.00%)

13:09
07/15/19
07/15
13:09
07/15/19
13:09
Hot Stocks
Osram announces interest from AMS, sees 'rather low' probability of deal »

Osram Licht said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAESY

BAE Systems

$0.00

(0.00%)

13:09
07/15/19
07/15
13:09
07/15/19
13:09
Hot Stocks
BAE Systems reports award of $45M contract from U.S. Army »

The U.S. Army has awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBGI

Sinclair Broadcast

$58.58

-0.46 (-0.78%)

, GIII

G-III Apparel

$28.05

-0.36 (-1.27%)

13:07
07/15/19
07/15
13:07
07/15/19
13:07
On The Fly
Fly Insider: G-III, Target among week's notable insider transactions »

Welcome to "Fly Insider,"…

SBGI

Sinclair Broadcast

$58.58

-0.46 (-0.78%)

GIII

G-III Apparel

$28.05

-0.36 (-1.27%)

OPK

Opko Health

$2.14

-0.025 (-1.15%)

THO

Thor Industries

$58.96

-0.4 (-0.67%)

GEF

Greif

$33.90

-0.68 (-1.97%)

INSG

Inseego

$5.19

0.03 (0.58%)

FDS

FactSet

$293.90

-2.66 (-0.90%)

TREE

LendingTree

$428.63

-4.28 (-0.99%)

MKC

McCormick

$159.84

1.31 (0.83%)

TGT

Target

$86.80

-0.73 (-0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 12

    Aug

  • 21

    Aug

  • 05

    Sep

  • 19

    Sep

  • 19

    Sep

  • 25

    Sep

  • 13

    Nov

YELP

Yelp

$35.68

-0.37 (-1.03%)

13:05
07/15/19
07/15
13:05
07/15/19
13:05
Options
Yelp call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONN

Conn's

$18.07

-0.21 (-1.15%)

13:03
07/15/19
07/15
13:03
07/15/19
13:03
Hot Stocks
Conn's settles with SEC over underwriting policies, bad debt provisions »

Conn's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

ET

Energy Transfer LP

$14.82

(0.00%)

13:02
07/15/19
07/15
13:02
07/15/19
13:02
Hot Stocks
Energy Transfer LP announce binding supplemental open season for Bakken »

Energy Transfer LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$45.86

-0.17 (-0.37%)

13:02
07/15/19
07/15
13:02
07/15/19
13:02
Hot Stocks
Blackstone agrees to acquire Vungle, terms not disclosed »

Blackstone announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

BIDU

Baidu

$115.31

0.41 (0.36%)

, SNAP

Snap

$15.59

-0.01 (-0.06%)

13:02
07/15/19
07/15
13:02
07/15/19
13:02
Hot Stocks
Baidu, Snap renew sales partnership »

Baidu (BIDU) and Snap…

BIDU

Baidu

$115.31

0.41 (0.36%)

SNAP

Snap

$15.59

-0.01 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 23

    Jul

INTC

Intel

$49.91

(0.00%)

, AMD

AMD

$34.42

1.22 (3.67%)

12:56
07/15/19
07/15
12:56
07/15/19
12:56
Recommendations
Intel, AMD analyst commentary at RBC Capital »

RBC sees AMD continuing…

INTC

Intel

$49.91

(0.00%)

AMD

AMD

$34.42

1.22 (3.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

FB

Facebook

$203.64

-1.265 (-0.62%)

12:52
07/15/19
07/15
12:52
07/15/19
12:52
Hot Stocks
Facebook's Marcus says company won't immediately profit from Libra »

In testimony for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 24

    Jul

CYTK

Cytokinetics

$11.04

0.02 (0.18%)

, AMGN

Amgen

$177.08

2.21 (1.26%)

12:51
07/15/19
07/15
12:51
07/15/19
12:51
Recommendations
Cytokinetics, Amgen analyst commentary at Piper Jaffray »

Piper reiterates…

CYTK

Cytokinetics

$11.04

0.02 (0.18%)

AMGN

Amgen

$177.08

2.21 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 09

    Sep

  • 16

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.